HMGB1 and neoplasm: In HMGB1-deficient subcutaneous tumor model mice, both the therapeutic efficacy of ADVNE and ADVPPE and their ability to promote M1 macrophage polarization and TEM/TE infiltration in the tumor microenvironment were significantly reduced.